Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
COLTENE Holding AG (CLTN.SW)
CHF51.90
+1.00 (+1.96%)
CH SIX Healthcare Medical - Instruments & Supplies
Address
Feldwiesenstrasse 20 9450
Altstätten, CH
Altstätten, CH
CEO
Dominik Arnold
Website
coltene.com
IPO
2006-06-23
ISIN CH0025343259
Also trades on
London Stock Exchange · 0QP7.L (CHF)
Other OTC · CLHLF (USD)
Swiss Exchange · CLTN.SW (CHF)
Description
Headquartered in Altstätten, Switzerland, COLTENE Holding AG, established in 2005 and formerly known as Medisize Holding AG until its name change in April 2008, is a global leader in the development, manufacturing, and sale of a diverse range of consumables, instruments, and equipment specifically designed for dentists and dental laboratories. The company's comprehensive product line addresses various aspects of dental care across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. Key offerings include advanced materials for restorations, such as conventional and bulk-fill composites, CAD/CAM solutions, bonding agents, and curing lights. For endodontic procedures, they provide specialized tools like rotary and hand files, irrigation solutions, and obturation materials. Their prosthetics segment features products for bite registration and impression materials like A-silicones and C-silicones. Additionally, COLTENE supplies essential treatment auxiliaries, including dental rolls, aspirator tips, and dental dams; infection control solutions such as ultrasonic cleaning units and patient bibs; and a variety of rotary instruments, including diamond and carbide burs. The company also offers a full suite of laboratory products, encompassing gingiva masks, model making materials, and specialized burs and polishers.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CHF51.90
+1.00 (+1.96%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3.5K
Beta
0.85
Float Shares
2.58M
Free Float %
43.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.18% | +0.59% | +10.09% | -10.47% | +2.81% | -6.73% | -23.20% | -28.55% | -59.35% | -13.91% | -44.84% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
51.90
DCF (Unlevered)
52.29
+0.8%
DCF (Levered)
36.95
-28.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | -1 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.37
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%-4.0% Q4'25: +9.6% (vs Q4'23)
-
EPS growth Medical - Instruments & Supplies: +16.3%-26.9% Q4'25: +459.4% (vs Q4'23)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+4.1% Q4'25: +7.6% (vs Q4'23)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+8.5% Q4'25: +10.6% (vs Q4'23)
-
ROIC Medical - Instruments & Supplies: +6.0%+13.1% ★ Q4'25: +34.0% (vs Q4'23)
-
Share dilution Medical - Instruments & Supplies: +0.1%0.0% Q4'25: 0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.70× Q4'25: 0.70× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
249.86M
est: 261.48M (-4.4%)
|
274.23M
est: 277.46M (-1.2%)
|
166.42M
est: 170.15M (-2.2%)
|
151.39M
est: 155.68M (-2.8%)
|
153.58M
est: 158.65M (-3.2%)
|
146.13M
est: 148.94M (-1.9%)
|
158.08M
est: 152.22M (+3.8%)
|
160.01M
est: 167.98M (-4.7%)
|
162.35M
est: 165.78M (-2.1%)
|
154.50M
est: 156.00M (-1.0%)
|
160.67M
est: 162.50M (-1.1%)
|
167.99M
est: 171.00M (-1.8%)
|
203.95M
est: 202.40M (+0.8%)
|
273.83M
est: 273.90M (0.0%)
|
248.35M
est: 243.20M (+2.1%)
|
279.24M
est: 279.87M (-0.2%)
|
267.13M
est: 267.07M (+0.0%)
|
242.73M
est: 238.80M (+1.6%)
|
250.16M
est: 251.96M (-0.7%)
|
240.05M
est: 240.18M (-0.1%)
|
236.65M
234.32M – 238.26M
-1.5% YoY
|
242.55M
240.84M – 244.23M
+2.5% YoY
|
249.30M
247.75M – 250.85M
+2.8% YoY
|
264.80M
262.57M – 266.62M
+6.2% YoY
|
| EBITDA |
41.95M
est: 34.67M (+21.0%)
|
30.25M
est: 39.35M (-23.1%)
|
27.44M
est: 25.33M (+8.3%)
|
25.13M
est: 50.61M (-50.3%)
|
18.67M
est: 25.43M (-26.6%)
|
15.13M
est: 10.81M (+39.9%)
|
21.38M
est: 10.86M (+96.8%)
|
23.07M
est: 19.84M (+16.3%)
|
27.09M
est: 19.53M (+38.7%)
|
25.87M
est: 23.60M (+9.6%)
|
29.41M
est: 21.54M (+36.5%)
|
31.19M
est: 30.61M (+1.9%)
|
30.94M
est: 34.73M (-10.9%)
|
35.02M
est: 38.08M (-8.0%)
|
26.48M
est: 23.86M (+11.0%)
|
48.05M
est: 27.38M (+75.5%)
|
39.88M
est: 28.85M (+38.2%)
|
23.80M
est: 32.08M (-25.8%)
|
34.23M
est: 33.82M (+1.2%)
|
27.70M
est: 32.27M (-14.1%)
|
31.79M
31.48M – 32.01M
-1.5% YoY
|
32.58M
32.36M – 32.81M
+2.5% YoY
|
33.49M
33.28M – 33.70M
+2.8% YoY
|
35.57M
35.27M – 35.82M
+6.2% YoY
|
| EBIT |
33.16M
est: 27.96M (+18.6%)
|
26.05M
est: 31.94M (-18.4%)
|
25.54M
est: 21.59M (+18.3%)
|
20.78M
est: 22.78M (-8.8%)
|
15.89M
est: 20.69M (-23.2%)
|
10.20M
est: 17.27M (-41.0%)
|
16.42M
est: 12.57M (+30.6%)
|
17.88M
est: 18.78M (-4.8%)
|
21.82M
est: 19.15M (+14.0%)
|
20.40M
est: 21.50M (-5.1%)
|
23.80M
est: 21.01M (+13.3%)
|
25.48M
est: 24.45M (+4.2%)
|
23.61M
est: 30.26M (-22.0%)
|
28.92M
est: 36.42M (-20.6%)
|
20.45M
est: 25.14M (-18.7%)
|
41.62M
est: 28.86M (+44.2%)
|
33.17M
est: 30.41M (+9.1%)
|
16.96M
est: 25.68M (-34.0%)
|
27.34M
est: 27.07M (+1.0%)
|
20.49M
est: 25.83M (-20.7%)
|
25.45M
25.20M – 25.62M
-1.5% YoY
|
26.08M
25.90M – 26.26M
+2.5% YoY
|
26.81M
26.64M – 26.97M
+2.8% YoY
|
28.47M
28.23M – 28.67M
+6.2% YoY
|
| Net Income |
22.64M
est: 27.81M (-18.6%)
|
26.30M
est: 23.98M (+9.6%)
|
48.07M
est: 16.13M (+198.1%)
|
16.36M
est: 44.01M (-62.8%)
|
9.29M
est: 16.71M (-44.4%)
|
5.99M
est: 8.73M (-31.4%)
|
9.53M
est: 6.13M (+55.4%)
|
13.19M
est: 10.49M (+25.7%)
|
15.63M
est: 13.03M (+20.0%)
|
13.34M
est: 15.00M (-11.1%)
|
17.27M
est: 13.75M (+25.6%)
|
19.06M
est: 18.11M (+5.2%)
|
14.91M
est: 22.63M (-34.1%)
|
20.03M
est: 24.40M (-17.9%)
|
8.23M
est: 15.73M (-47.7%)
|
31.71M
est: 18.06M (+75.6%)
|
26.00M
est: 23.90M (+8.8%)
|
11.95M
est: 12.34M (-3.2%)
|
20.47M
est: 20.47M (0.0%)
|
14.94M
est: 17.36M (-13.9%)
|
18.33M
17.90M – 19.42M
+5.5% YoY
|
19.82M
19.41M – 21.49M
+8.1% YoY
|
21.96M
21.75M – 22.18M
+10.8% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
82.92M
est: 32.36M (+156.3%)
|
90.15M
est: 119.27M (-24.4%)
|
26.21M
est: 77.45M (-66.2%)
|
—
est: 76.49M (-100.0%)
|
—
est: 54.93M (-100.0%)
|
—
est: 51.92M (-100.0%)
|
—
est: 54.88M (-100.0%)
|
57.05M
est: 60.97M (-6.4%)
|
64.89M
est: 56.25M (+15.4%)
|
15.01M
est: 53.55M (-72.0%)
|
17.13M
est: 71.46M (-76.0%)
|
17.20M
est: 76.57M (-77.5%)
|
23.36M
est: 90.83M (-74.3%)
|
41.55M
est: 149.54M (-72.2%)
|
27.97M
est: 109.80M (-74.5%)
|
33.79M
est: 126.03M (-73.2%)
|
34.74M
est: 132.80M (-73.8%)
|
30.77M
est: 30.68M (+0.3%)
|
32.10M
est: 162.32M (-80.2%)
|
32.72M
est: 30.86M (+6.0%)
|
30.41M
30.11M – 30.61M
-1.5% YoY
|
31.16M
30.95M – 31.38M
+2.5% YoY
|
32.03M
31.83M – 32.23M
+2.8% YoY
|
34.02M
33.74M – 34.26M
+6.2% YoY
|
| EPS |
4.88
est: 4.66 (+4.8%)
|
5.67
est: 5.65 (+0.4%)
|
10.55
est: 4.36 (+142.2%)
|
3.94
est: 3.40 (+15.9%)
|
2.24
est: 3.93 (-43.0%)
|
1.36
est: 1.35 (+0.9%)
|
2.33
est: 1.98 (+17.5%)
|
3.13
est: 3.23 (-3.1%)
|
3.71
est: 3.61 (+2.7%)
|
3.16
est: 3.03 (+4.4%)
|
4.10
est: 4.12 (-0.4%)
|
4.52
est: 4.76 (-5.1%)
|
3.16
est: 4.63 (-31.8%)
|
3.35
est: 3.36 (-0.3%)
|
1.38
est: 2.32 (-40.5%)
|
5.31
est: 5.06 (+4.9%)
|
4.35
est: 4.07 (+6.9%)
|
2.00
est: 2.06 (-3.0%)
|
3.42
est: 3.43 (-0.3%)
|
2.50
est: 2.85 (-12.3%)
|
3.10
3.00 – 3.25
+8.6% YoY
|
3.44
3.25 – 3.60
+11.1% YoY
|
3.68
3.64 – 3.71
+7.0% YoY
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
29.27M
OE per share TTM
4.89
Owner's Yield
9.55%
Maintenance CapEx ratio
9.24%
Maint CapEx / Avg PPE
18.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 8 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 167.6K | 0.40% |
| 2 | iShares Core SPI(R) ETF (CH) CHSPI.SW | 0.01% | 579.1K | 0.10% |
| 3 | Dimensional - International Small Cap ETF DFIS | 0.00% | 234.5K | 0.39% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 164.6K | 0.22% |
| 5 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | 170.6K | 0.18% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 83.3K | 0.28% |
| 7 | Avantis International Equity ETF AVDE | 0.00% | 55.2K | 0.23% |
| 8 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | — | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
17.4K
Shares Outstanding
5.98M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dominik Arnold | Chief Executive Officer | 789.8K | male |
| Di Hu | Vice President of Sales & Marketing Communication EU&ROW (CSO) | — | male |
| Gregor Picard | Chief Operating Officer | — | male |
| Markus Abderhalden | Chief Financial Officer | — | male |
| Mattias Flodin | Chief Marketing Officer | — | male |
| Paul Frey | Chief Sales Officer of North America | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for CLTN.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
